GLSI
Greenwich LifeSciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$15.95
+2.05%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-695.6%
Return on equity
-244.2%
Return on assets
-701.6%
Return on invested capital
0.00x
Asset turnover
-$12.5M
Cash from operations
$0.60
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026